This report contains market size and forecasts of 5-Hydroxytryptamine Receptor Agonist in global, including the following market information:
Global 5-Hydroxytryptamine Receptor Agonist Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global 5-Hydroxytryptamine Receptor Agonist Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five 5-Hydroxytryptamine Receptor Agonist companies in 2021 (%)
The global 5-Hydroxytryptamine Receptor Agonist market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Dolasetron Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of 5-Hydroxytryptamine Receptor Agonist include Heron Therapeutics, Kyowa Kirin, Bionpharma, Fresenius Kabi, Aurobindo Pharma, Mylan NV, Sun Pharmaceutical Industries, Akron Incorporated and Hikma Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the 5-Hydroxytryptamine Receptor Agonist manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global 5-Hydroxytryptamine Receptor Agonist Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global 5-Hydroxytryptamine Receptor Agonist Market Segment Percentages, by Type, 2021 (%)
Dolasetron
Granisetron
Ondansetron
Tropisetron
Others
Global 5-Hydroxytryptamine Receptor Agonist Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global 5-Hydroxytryptamine Receptor Agonist Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Global 5-Hydroxytryptamine Receptor Agonist Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global 5-Hydroxytryptamine Receptor Agonist Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies 5-Hydroxytryptamine Receptor Agonist revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies 5-Hydroxytryptamine Receptor Agonist revenues share in global market, 2021 (%)
Key companies 5-Hydroxytryptamine Receptor Agonist sales in global market, 2017-2022 (Estimated), (K Units)
Key companies 5-Hydroxytryptamine Receptor Agonist sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Heron Therapeutics
Kyowa Kirin
Bionpharma
Fresenius Kabi
Aurobindo Pharma
Mylan NV
Sun Pharmaceutical Industries
Akron Incorporated
Hikma Pharmaceuticals
Dr. Reddy's Laboratories
Cipla
Novartis
Glenmark Pharmaceuticals
Apotex
Novo Nordisk
Otsuka America Pharmaceutical
Bristol-Myers Squibb Company
Teva Pharmaceutical Industries
WOCKHARDT